Home > Boards > Canadian > Cannabis > Tilray, Inc (TLRY)

Tilray, Inc. Reports 2021 Fiscal Year and Fourth

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JohnCM Member Profile
 
Followed By 654
Posts 60,039
Boards Moderated 18
Alias Born 06/01/08
160x600 placeholder
JohnCM   Wednesday, 08/11/21 12:51:29 AM
Re: None
Post # of 7999 
Quote:
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
Net Revenue Increased 27% to $513 Million Compared to Prior Year


Net Income of $33.6 Million, Adjusted EBITDA of $12.3 Million, Net Cash from Operating Activities of $8.3 Million and Positive Free Cash Flow of $3.3 Million in Q4

Completed Business Combination with Aphria Inc., Achieved $35 Million in Synergies To Date; On-track for $80 Million Target

Cannabis Revenue Grew 55% in Q4, #1 Market Share in Canada

Leading EU GMP-Certified Medical Cannabis LP in Europe with Demand Growing

Executive Leadership Executing On Plan to Drive Accelerated Growth and Sustained Profitability in Global Cannabis Market

Financial Highlights - 2021 Fiscal Fourth Quarter

Net revenue increased 25% to $142.2 million during the fourth quarter from $113.5 million in the prior year quarter. The increase was driven by 36% growth in net cannabis revenue to $53.7 million, which included four weeks of contribution from legacy-Tilray, a 10% decline in distribution revenue, net beverage alcohol revenue of $15.9 million following our SweetWater acquisition on November 25, 2020, and wellness revenue of $5.8 million from Manitoba Harvest.

Net income of $33.6 million during the fourth quarter compared to net loss of $84.3 million in the prior year quarter.

Adjusted EBITDA increased 285% to $12.3 million during the fourth quarter from $3.2 million in the prior year quarter marking the ninth consecutive quarter of positive Adjusted EBITDA.

Gross profit decreased 19% to $22.5 million during the fourth quarter from $27.8 million in the prior year quarter. Included in gross profit was a one-time inventory valuation adjustment of $19.9 million resulting from excess inventory quantities upon the business combination with Aphria.

Adjusted gross profit, excluding inventory valuation adjustment, increased 53% to $42.4 million during the fourth quarter from $27.8 million in the prior year quarter.

Free cash flow increased 112% to $3.3 million in the fourth quarter from ($28.3) million in the prior year quarter.



Discussion Board CRYPTOCURRENCY ROUNDTABLE
For sharing information ... tips, tricks, Q&A.
https://investorshub.advfn.com/Cryptocurrency-Roundtable-39717/
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences